These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 16507420)

  • 1. Rejection with hemodynamic compromise: objective evidence for efficacy of photopheresis.
    Kirklin JK; Brown RN; Huang ST; Naftel DC; Hubbard SM; Rayburn BK; McGiffin DC; Bourge RB; Benza RL; Tallaj JA; Pinderski LJ; Pamboukian SV; George JF; Marques M
    J Heart Lung Transplant; 2006 Mar; 25(3):283-8. PubMed ID: 16507420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extracorporeal Photopheresis Reduces Fibrotic and Inflammatory Transcriptomic Biological Marker of Chronic Antibody-mediated Kidney Rejection.
    Lionet A; Van Triempon M; Figeac M; Fages V; Gibier JB; Provot F; Maanaoui M; Pottier N; Cauffiez C; Glowacki F
    Transplant Direct; 2024 Mar; 10(3):e1587. PubMed ID: 38380348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of extracorporeal photopheresis in kidney transplant recipients: technical considerations and procedure tolerance.
    Kusztal M; Kłak R; Krajewska M; Boratyńska M; Patrzałek D; Klinger M
    Transplant Proc; 2011 Oct; 43(8):2941-2. PubMed ID: 21996195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of severe scleroderma with long-term extracorporeal photopheresis.
    Krasagakis K; Dippel E; Ramaker J; Owsianowski M; Orfanos CE
    Dermatology; 1998; 196(3):309-15. PubMed ID: 9621138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Photopheresis for the prevention of rejection in cardiac transplantation. Photopheresis Transplantation Study Group.
    Barr ML; Meiser BM; Eisen HJ; Roberts RF; Livi U; Dall'Amico R; Dorent R; Rogers JG; Radovancević B; Taylor DO; Jeevanandam V; Marboe CC
    N Engl J Med; 1998 Dec; 339(24):1744-51. PubMed ID: 9845709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extracorporeal photopheresis for the treatment of graft rejection in 33 adult kidney transplant recipients.
    Tamain M; Sayegh J; Lionet A; Grimbert P; Philipponnet C; Hazzan M; Augusto JF; Büchler M; Merlin E; Kosmadakis G; Tiple A; Pereira B; Garrouste C; Heng AE
    Transfus Apher Sci; 2019 Aug; 58(4):515-524. PubMed ID: 31383541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. De Novo Donor-Specific Antibodies after Heart Transplantation: A Comprehensive Guide for Clinicians.
    Marco I; López-Azor García JC; González Martín J; Severo Sánchez A; García-Cosío Carmena MD; Mancebo Sierra E; de Juan Bagudá J; Castrodeza Calvo J; Hernández Pérez FJ; Delgado JF
    J Clin Med; 2023 Dec; 12(23):. PubMed ID: 38068526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extracorporeal Photopheresis Improves Graft Survival in a Full-Mismatch Rat Model of Kidney Transplantation.
    Piñeiro GJ; Lazo-Rodriguez M; Ventura-Aguiar P; Ramirez-Bajo MJ; Banon-Maneus E; Lozano M; Cid J; Hierro-Garcia N; Cucchiari D; Revuelta I; Montagud-Marrahi E; Palou E; Bayés-Genís B; Campistol JM; Diekmann F; Rovira J
    Transpl Int; 2023; 36():10840. PubMed ID: 36713113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heart Transplant Immunosuppression Strategies at Cedars-Sinai Medical Center.
    Chang DH; Youn JC; Dilibero D; Patel JK; Kobashigawa JA
    Int J Heart Fail; 2021 Jan; 3(1):15-30. PubMed ID: 36263111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pre-transplant infusion of donor leukocytes treated with extracorporeal photochemotherapy induces immune hypo-responsiveness and long-term allograft survival in murine models.
    Schneiderman J; Qiu L; Yeap XY; Kang X; Zheng F; Ye J; Xie Y; Wang JJ; Sambandam Y; Mathew J; Li L; Leventhal J; Edelson RL; Zhang ZJ
    Sci Rep; 2022 May; 12(1):7298. PubMed ID: 35508582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extracorporeal Photopheresis With Low-Dose Immunosuppression in High-Risk Heart Transplant Patients-A Pilot Study.
    Gökler J; Aliabadi-Zuckermann A; Zuckermann A; Osorio E; Knobler R; Moayedifar R; Angleitner P; Leitner G; Laufer G; Worel N
    Transpl Int; 2022; 35():10320. PubMed ID: 35401042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD11c
    Hackstein H; Kalina A; Dorn B; Keil IS; Baal N; Michel G; Brendel C; Neubauer A; Jakob T; Bein G
    Clin Exp Immunol; 2021 Feb; 203(2):329-339. PubMed ID: 33073358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. European dermatology forum: Updated guidelines on the use of extracorporeal photopheresis 2020 - Part 2.
    Knobler R; Arenberger P; Arun A; Assaf C; Bagot M; Berlin G; Bohbot A; Calzavara-Pinton P; Child F; Cho A; French LE; Gennery AR; Gniadecki R; Gollnick HPM; Guenova E; Jaksch P; Jantschitsch C; Klemke C; Ludvigsson J; Papadavid E; Scarisbrick J; Schwarz T; Stadler R; Wolf P; Zic J; Zouboulis C; Zuckermann A; Greinix H
    J Eur Acad Dermatol Venereol; 2021 Jan; 35(1):27-49. PubMed ID: 32964529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extracorporeal Photopheresis-An Overview.
    Cho A; Jantschitsch C; Knobler R
    Front Med (Lausanne); 2018; 5():236. PubMed ID: 30211164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of extracorporeal photopheresis in the management of cutaneous T-cell lymphoma, graft-versus-host disease and organ transplant rejection: a consensus statement update from the UK Photopheresis Society.
    Alfred A; Taylor PC; Dignan F; El-Ghariani K; Griffin J; Gennery AR; Bonney D; Das-Gupta E; Lawson S; Malladi RK; Douglas KW; Maher T; Guest J; Hartlett L; Fisher AJ; Child F; Scarisbrick JJ
    Br J Haematol; 2017 Apr; 177(2):287-310. PubMed ID: 28220931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quilty effect after extracorporeal photopheresis in a patient with severe refractory cardiac allograft rejection.
    Özcan ÖU; Sayın T; Soğut G; Heper A; Göksülük H; Vurgun VK; Kaya CT; Üstün EE; İlhan O; Erol Ç
    Turk J Haematol; 2014 Dec; 31(4):430-1. PubMed ID: 25541667
    [No Abstract]   [Full Text] [Related]  

  • 17. Guidelines on the use of extracorporeal photopheresis.
    Knobler R; Berlin G; Calzavara-Pinton P; Greinix H; Jaksch P; Laroche L; Ludvigsson J; Quaglino P; Reinisch W; Scarisbrick J; Schwarz T; Wolf P; Arenberger P; Assaf C; Bagot M; Barr M; Bohbot A; Bruckner-Tuderman L; Dreno B; Enk A; French L; Gniadecki R; Gollnick H; Hertl M; Jantschitsch C; Jung A; Just U; Klemke CD; Lippert U; Luger T; Papadavid E; Pehamberger H; Ranki A; Stadler R; Sterry W; Wolf IH; Worm M; Zic J; Zouboulis CC; Hillen U
    J Eur Acad Dermatol Venereol; 2014 Jan; 28 Suppl 1(Suppl 1):1-37. PubMed ID: 24354653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunological monitoring of extracorporeal photopheresis after heart transplantation.
    Dieterlen MT; Bittner HB; Pierzchalski A; Dhein S; Mohr FW; Barten MJ
    Clin Exp Immunol; 2014 Apr; 176(1):120-8. PubMed ID: 24329680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of the ACC/AHA Stage D patient: cardiac transplantation.
    Kittleson MM; Kobashigawa JA
    Cardiol Clin; 2014 Feb; 32(1):95-112, viii. PubMed ID: 24286581
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.